Barclays’s Protagonist Therapeutics PTGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$11.7M Buy
212,112
+100,680
+90% +$5.56M ﹤0.01% 1070
2025
Q1
$5.39M Sell
111,432
-15,301
-12% -$740K ﹤0.01% 1371
2024
Q4
$4.89M Sell
126,733
-262
-0.2% -$10.1K ﹤0.01% 1626
2024
Q3
$5.71M Buy
126,995
+87,755
+224% +$3.95M ﹤0.01% 1439
2024
Q2
$1.36M Sell
39,240
-22,579
-37% -$783K ﹤0.01% 1938
2024
Q1
$1.79M Sell
61,819
-87,155
-59% -$2.52M ﹤0.01% 2023
2023
Q4
$3.42M Sell
148,974
-27,863
-16% -$639K ﹤0.01% 1778
2023
Q3
$2.95M Sell
176,837
-16,602
-9% -$277K ﹤0.01% 1449
2023
Q2
$5.34M Sell
193,439
-390,298
-67% -$10.8M ﹤0.01% 1193
2023
Q1
$13.4M Buy
583,737
+328,850
+129% +$7.56M 0.01% 727
2022
Q4
$2.78M Buy
254,887
+38,893
+18% +$424K ﹤0.01% 1437
2022
Q3
$1.82M Buy
215,994
+192,463
+818% +$1.62M ﹤0.01% 1724
2022
Q2
$186K Sell
23,531
-20,771
-47% -$164K ﹤0.01% 3172
2022
Q1
$1.05M Sell
44,302
-76,295
-63% -$1.81M ﹤0.01% 2268
2021
Q4
$4.12M Buy
120,597
+83,600
+226% +$2.86M ﹤0.01% 1360
2021
Q3
$656K Buy
36,997
+29,592
+400% +$525K ﹤0.01% 2473
2021
Q2
$333K Sell
7,405
-30,461
-80% -$1.37M ﹤0.01% 2671
2021
Q1
$981K Buy
37,866
+27,258
+257% +$706K ﹤0.01% 2315
2020
Q4
$214K Sell
10,608
-3,919
-27% -$79.1K ﹤0.01% 2674
2020
Q3
$284K Buy
14,527
+1,936
+15% +$37.8K ﹤0.01% 2571
2020
Q2
$222K Buy
12,591
+6,698
+114% +$118K ﹤0.01% 2757
2020
Q1
$42K Sell
5,893
-12,561
-68% -$89.5K ﹤0.01% 3174
2019
Q4
$130K Buy
18,454
+3,956
+27% +$27.9K ﹤0.01% 3362
2019
Q3
$174K Sell
14,498
-10,477
-42% -$126K ﹤0.01% 3124
2019
Q2
$302K Sell
24,975
-39,594
-61% -$479K ﹤0.01% 2983
2019
Q1
$812K Sell
64,569
-4,033
-6% -$50.7K ﹤0.01% 2299
2018
Q4
$462K Buy
+68,602
New +$462K ﹤0.01% 2301
2018
Q3
Sell
-24,527
Closed -$164K 4433
2018
Q2
$164K Buy
24,527
+12,650
+107% +$84.6K ﹤0.01% 2837
2018
Q1
$102K Buy
11,877
+3,661
+45% +$31.4K ﹤0.01% 3159
2017
Q4
$171K Buy
8,216
+8,000
+3,704% +$167K ﹤0.01% 2734
2017
Q3
$4K Sell
216
-248
-53% -$4.59K ﹤0.01% 3722
2017
Q2
$5K Sell
464
-1,171
-72% -$12.6K ﹤0.01% 3545
2017
Q1
$20K Buy
1,635
+1,417
+650% +$17.3K ﹤0.01% 3373
2016
Q4
$5K Buy
+218
New +$5K ﹤0.01% 3439